Sinovac To Provide Latest Clinical Data: Expert

"); jQuery("#212 h3").html("

"); });
2021-03-21 HKT 12:07
An expert adviser to the government on Covid-19 inoculation, Wallace Lau, said he expects Sinovac to submit the latest clinical data on the efficacy and side effects of its vaccine to the government shortly.
Speaking on a television programme on Sunday, Lau said vaccine manufacturers had a responsibility to provide authorities with the most updated clinical information about their products.
The expert said while there is no evidence to show that either of the coronavirus vaccines currently in use in the SAR – Sinovac or BioNtech – can trigger problems like vascular occlusion or coronary heart diseases, it's important for the government to keep people informed of the data to boost public confidence.
Government advisers are to meet on Wednesday to discuss the death of a man who had recently received the BioNTech jab.
However they said that, as with the case of seven people who died after receiving Sinovac inoculations, there's no evidence so far of a direct link.
HSBC Fined HK$4.2M Over Disclosure Breaches In Research Reports
The Securities and Futures Commission (SFC) has reprimanded and imposed a fine of HK$4.2 million on HSBC for breaching ... Read more
Philippines: The Hidden Fintech Gem You Cant Afford To Miss | Lito Villanueva
The Philippines is the fastest-growing digital economy and home to one of Southeast Asia’s most valuable fintech unic... Read more
SBI And Chainlink Partner On Blockchain And Digital Asset Use
SBI Group, one of Japan’s largest financial conglomerates with assets exceeding the equivalent of US$200 billion, has... Read more
China Considers Yuan-Backed Stablecoins To Advance Global Currency Push
China is considering permitting the use of yuan-backed stablecoins for the first time in a move that could support wide... Read more
Financial Sanctions: LSEG Risk Intelligence Answers Your Key Questions
Financial sanctions are essential government tools for achieving foreign policy objectives – and compliance is mandat... Read more
Korea Development Bank Leads $45M Bridge Round For Upstage
South Korea’s Upstage has secured a US$45 million Series B bridge round supported by Korea Development Bank (KDB), Am... Read more